Clinical Trials Directory

Trials / Unknown

UnknownNCT06069817

Impact of High Flow Therapy on Complications Related to Airway Stenting

Impact of High Flow Therapy Through Nasal Cannula on Complications Related to Airway Stenting: a Prospective, Multicentric, Randomized-controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Cardarelli Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The application of HFNC therapy in patients with airway stent, improving both humidification and clearance of the airway secretion, could potentially reduce the risk of mucoid impaction, respiratory infections and granulation. HFNC therapy could be superior to nebulization of normal saline (usual care) in order to keep the stent cleaned, reducing, by inference, the risk of complications, as defined above.

Conditions

Interventions

TypeNameDescription
DEVICEHigh flow nasal cannulahome treatment with HFNC after airway stent placement both for malignant and benignant central airway obstruction
DEVICEnebulized normal salinehome treatment with nebulized normal saline after airway stent placement both for malignant and benignant central airway obstruction

Timeline

Start date
2024-01-01
Primary completion
2024-11-01
Completion
2024-12-31
First posted
2023-10-06
Last updated
2024-02-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06069817. Inclusion in this directory is not an endorsement.

Impact of High Flow Therapy on Complications Related to Airway Stenting (NCT06069817) · Clinical Trials Directory